NTPC Green Energy declares COD for 75.5 MW Unit of Khavda-I Solar Project; NTPC Group Capacity Rises to 84,924 MW 
News Updates

NTPC Green Energy declares COD for 75.5 MW Unit of Khavda-I Solar Project

NTPC Green Energy Limited (NGEL) has declared the commercial operation date (COD) for 75.50 MW of the 1,255 MW Khavda-I Solar PV Project in Gujarat

PSU Watch Bureau

New Delhi: NTPC Limited on Wednesday announced that its subsidiary, NTPC Green Energy Limited (NGEL), has declared the commercial operation date (COD) for 75.50 MW of the 1,255 MW Khavda-I Solar PV Project in Gujarat. The project is being developed by NTPC Renewable Energy Limited (NREL), a step-down subsidiary of NTPC.

PSU Watch is now on Whatsapp Channels. Click here to join

The disclosure, made under Regulation 30 of SEBI’s Listing Obligations and Disclosure Requirements (LODR), states that the COD of the partial capacity has been effective from November 19. The project falls under the CPSU Scheme Phase-II, Tranche-III.

With the addition of this new solar capacity, the total installed and commercial capacity of the NTPC Group has increased to 84,924 MW, reaffirming the company’s continued expansion in the renewable energy domain.

The Khavda Solar complex is one of NTPC’s major renewable energy initiatives and forms a key part of India’s broader green energy transition and capacity augmentation under government-led schemes.

The company shared the disclosure with stock exchanges including BSE and NSE on Wednesday.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Google News. Click here to follow. Also, join PSU Watch Channel in your Telegram. You may also follow us on Twitter here and stay updated.)

ONGC incorporates JV with MRPL, OPaL to market group's petrochemicals

MNRE discusses hydrogen safety standards as India pushes for wider adoption

Goutam Ghosh appointed Executive Member of Narmada Control Authority

NVVN to synchronise first battery storage project of 500 MWh in days: CEO

Centre to cap cancer drug trade margins at 30%, cut prices of 110 medicines